Full Press Release Details
Precipio Announces Third Quarter 2018
Corporate Update Call for Shareholders
Conference Call to Be Held Monday, November
19, 2018 at 5:00 PM ET
NEW HAVEN, CT - (November 15, 2018)
- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:
PRPO) will be hosting its third quarter 2018 corporate update call on Monday, November
19 at 5:00 PM ET, following the expected filing on or before November 19 of its form 10-Q and release of its financial
results for the quarter ended September 30, 2018.
The conference call may be accessed
by calling 1-866-777-2509 (international callers dial 1-412-317-5413). All callers
should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference
call at http://dpregister.com/10126488 and will
receive a calendar invite and a direct dial-in number, bypassing the operator.
Listeners interested in submitting questions in advance should
email their questions to investors@precipiodx.com and management will do its best to
address those questions during the call.
A replay of the call will be available approximately 24 hours
after the call and may be accessed via the Investors page on Precipio's website, http://www.precipiodx.com/investors.html.
Precipio has built a platform designed to eradicate the problem
of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality
diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions
specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine and Harvard's Dana-Farber
Cancer Institute, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information,
please visit www.precipiodx.com.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking
statements," within the meaning of federal securities laws, including statements related to ICP technology, including financial
projections related thereto and potential market opportunity, plans and prospects and other statements containing the words "anticipate,"
"intend," "may," "plan," "predict," "will," "would," "could,"
"should," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. The Company's actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results
or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company's
definitive proxy statement filed on May 29, 2018, the Company's Quarterly Report on Form 10-Q for the quarter ended June
30, 2018 and on the Annual Report on Form 10-K for the year ended December 31, 2017 as well as the Company's prior filings
and from time to time in the Company's subsequent filings with the Securities and Exchange Commission. Any change in such
factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred
to in such statements. All information in this press release is as of the date of the release and the Company does not undertake
any duty to update this information, including any forward-looking statements, unless required by law.